Philadelphia-based Imvax recently announced it had dosed the first patient in its Phase IIb trial of IGV-001 in patients with newly diagnosed glioblastoma. Company CEO John Furey took time to speak with BioBuzz about the study and the company as a whole.
BioBuzz rounds up some of the top Philadelphia life sciences companies looking to strengthen their teams for the coming year. The companies offer multiple job listings in different departments for candidates with a wide range of skills and experience levels.
The Curtis, located in the heart of Center City Philadelphia, once housed Curtis Publishing, owner of beloved publications such as the Saturday Evening Post and Ladies Home Journal.
Philadelphia’s soaring life sciences commercial real estate market is being driven by the combination of strong demand for advanced lab and manufacturing facilities and near record low vacancy rates.
